1. Real-world effectiveness of dupilumab versus benralizumab and mepolizumab.;Bleecker;Allergy Asthma Proc,2024
2. The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: a real life experience.;Vural Solak;Allergy Asthma Proc,2024
3. Association of serum pertussis antibodies with acute asthma attacks in children.;Xie;Allergy Asthma Proc,2024
4. Consistent efficacy and safety of sublingual immunotherapy tablets across allergens and geographic regions.;Stranzl;Allergy Asthma Proc,2024
5. Clinical features, severity, and immunological changes during venom immunotherapy in children and adults;Buyuktiryaki;Allergy Asthma Proc,2024